EPISODE · Mar 18, 2026 · 6 MIN
Alcon and Lensar Call Off Merger
from Eyewire News: The Podcast · host Eyewire News
Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Alcon and Lensar Call Off Merger
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m